Upon activation, naive CD4 1 T cells differentiate into different lineages of effector T h subsets. Each subset is characterized by its unique cytokine profile and biological functions. T h 17, a newly described T h subset that produces IL-17, IL-17F and IL-22 in preference to other cytokines, has been shown to play an important role in clearing specific pathogens and in inducing autoimmune tissue inflammations. Over the last 2-3 years, significant progress has been made to understand the development and biological functions of T h 17 subset. Transforming growth factor b (TGF) together with IL-6 or IL-21 initiates the differentiation while IL-23 stabilizes the generation of T h 17 cells. The transcription factors of T h 17 cells [retinoid-related orphan receptor (ROR) gt, ROR-a and signal transducer and activator of transcription-3] have been described recently. Since TGF-b is essential for the generation of both T h 17 and regulatory T (T reg ) cells from naive T cells, which suggests a developmental link between T h 17 and T reg cells. Functions of these two subsets of T cells are, however, opposite to each other; T h 17 cells are highly pathogenic during the inflammatory process while T reg cells are crucial for inhibiting tissue inflammation and maintaining self-tolerance. Here, we review the recent information on differentiation and effector functions of T h 17 cells during inflammatory conditions.
Introduction

CD4
+ T cells are the crucial component of an adaptive immune response. Upon antigenic stimulation and cytokine signaling, naive CD4 + T cells activate and differentiate into various T h subsets (1) . The T h subsets were first classified >20 years ago by Mossman and Coffman who published landmark paper proposing a T h 1-T h 2 paradigm of T cells (2) . The T h 1-T h 2 hypothesis was proposed based on the observation that each subset of CD4 + T h cells produces different patterns of cytokines and induces different effector functions: T h 1 cells secrete high levels of IFN-c and IL-2 and are required for cell-mediated immunity against intracellular pathogens and T h 2 cells predominantly secrete IL-4, IL-5 and IL-13 and are required for clearing extracellular pathogens (3) (Fig. 1) . After the initial discovery of T h subsets, significant progress was made to understand their biology and differentiation pathways on both a cellular and a molecular level. T h 1-T h 2 subsets showed a differential gene profile and a signaling requirement for their phenotype and effector functions. Signal transducer and activator of transcription (STAT) proteins are the key signaling transcription elements in the T h subset differentiation pathway. STAT-4 ( Fig. 1 ) and STAT-1 play a significant role in maintaining and amplifying the T h 1 response (4, 5) . Similarly, STAT-6 activation is necessary for T h 2 development (6). Both T h 1 and T h 2 subsets require lineage-specific transcription factors for their development. T-bet is the master transcription factor for the differentiation of T h 1 cells while GATA-binding protein 3 (GATA-3) is required for T h 2 development (7, 8) (Fig. 1) . IL-12, a heterodimeric cytokine, composed of two subunits known as IL-12p35 and IL-12p40 (9) is a major factor that induces and maintains T h 1 cells.
Although T h 1 cells were considered to be the pathogenic effector T cells inducing organ-specific autoimmunity, a lack of protection against autoimmunity in IFN-cÀ/À and IFN-cRÀ/À mice raised the possibility that other T cell subset distinct from T h 1 or T h 2 subsets may exist that induces autoimmunity and tissue inflammation (10) . Recently, a new subset of IL-17-producing T cells with effector functions distinct from those of T h 1 and T h 2 cells has been identified and has been termed as T h 17 cells (11) (Fig. 1) .
In this article, we review the discovery of T h 17 cells in the mouse and outline the IL-17 cytokine family. We detail the interplay between T h 17 cells and regulatory T (T reg ) cells and describe the amplification and negative regulation of the T h 17 response and the transcription factors involved. We then discuss human T h 17 cells and their role in inflammation and infection.
Discovery of T h 17 cells
T h 1 cells with specificity for the self-antigen were shown to transfer autoimmunity in adoptive transfer experiments as well (12) . T h 1 clones specific for MBP, myelin oligodendrocyte glycoprotein (MOG) and proteolipid protein were shown to transfer disease in adoptive transfer model (13) . Genetic deficiencies of T h 1 molecules such as IL-12p35, IL-12Rb2, STAT-1 and IFN-cR did not, however, abrogate experimental autoimmune encephalomyelitis (EAE) but rather enhanced the disease incidence and severity (14) . In 2000, Bob Kasteline identified another cytokine chain called p19, which appeared to associate with an already existing IL-12p40 chain. This cytokine was named as IL-23 (9) . The fundamental differences between IL-12 and IL-23 became evident after analysis of the expression profiles of their receptors, particularly on T cells. There are two IL-12R chains (IL-12Rb1 and IL-12Rb2), IL-23R pairs with IL-12Rb1 to form a functional IL-23R complex. Unlike the IL-23R that was expressed on memory effector T cells and activated effector T cells (15) , IL-12R b2 expression was detected on naive T cells. These observations imply that IL-12 and IL-23 might support T h 1 subsets at different time points during their differentiation. The transgenic expression of p19, however, induced a striking phenotype, characterized by an elevated expression of pro-inflammatory cytokines such as tumor necrosis factor (TNF) a and IL-1 as well as systemic inflammation characterized by neutrophilic infiltrations. The T cells and macrophage of transgenic mice infiltrated multiple organs and mice died at the age of 3 months (16) . The importance of IL-23 in the development of autoimmunity, especially EAE, was explored in a landmark experiment. In this experiment, Dan Cua et al. (17) induced EAE in IL-12p35-, IL-12p40-and IL-23p19-deficient mice. While genetic deficiency of IL-12 (p35) had no effect on the development of EAE, the loss of IL-23 (IL-12p40 or IL-23p19) led to a resistance against EAE in these genetically deficient mouse strains. These observations not only challenged the role of T h 1 cells in autoimmune inflammation but also showed that IL-23 (IL-12p40 and IL-23p19) is a crucial cytokine required for the development of EAE. Interestingly, T h 1 cells were not deficient in p19À/À EAE-resistant mice (17) . Furthermore, p35 subunit-deficient mice, which lack IL-12 but express functional IL-23, had less IFN-csecreting cells but still developed very severe EAE (18) . These unexpected findings have not only suggested the role of IL-23 and T h 1 cells in EAE but also raised the possibility of IL-23 responding cell involvement in inducing tissue inflammation and EAE. IL-23 was later shown to induce IL-17 from activated T cells (19) . IL-17-producing T cells (T h 17) were detected in many autoimmune diseases, including arthritis (20) and EAE (21) , suggesting a possible link between IL-23 and IL-17 during inflammatory responses. Moreover, EAE-resistant p19-deficient mice showed a dramatic decrease in IL-17-producing CD4 + T cell yet harbored normal numbers of T h 1 cells (22) . IL-23 did not trigger IFN-c induction in CD4 + T cells. In fact, IL-23-responsive CD4
+ T cells produced IL-17, IL-17F, IL-6 and TNF-a. Adoptive transfer of these pathogenic T h 17 cells induces severe EAE. Strikingly, IL-23-driven CD4
+ T cells showed a unique profile of gene expression, which differed from the profile of IL-12-driven T h 1 cells (23) . These observations clearly indicated that IL-23 induces an effector T cell population-distinct from known T h subsets, such as T h 1 and T h 2-that predominantly produces IL-17. With the series of experiments, the IL-23-T h 17 axis has been established as a dominant player in the induction and development of autoimmune inflammations such as arthritis and EAE. 
IL-17 cytokine family
IL-17, originally described as CTL-associated antigen 8, showed a 57% polypeptide sequence homology with immediate early gene 13 of Herpesvirus Saimiri (24) . Further studies showed that IL-17 induced the activation of the nuclear factor jB (NFjB)/mitogen-activated protein kinase pathways and the secretion of IL-6 from fibroblast (25, 26) . A cDNA encoding human IL-17 was cloned from a CD4 + T cell library. This cDNA showed a 72% amino acid identity with HVS13 and a 63% amino acid identity with murine IL-17. Five other IL-17 family members were uncovered, leading to designation of IL-17A-F. IL-17A, the prototypic family member, is a disulfide-linked, homodimeric glycoprotein that possesses a typical cysteine knot structure. Among the other family members, only IL-17A, IL-17F and IL-17E (IL-25) are better characterized (27) . IL-17F and IL-17A showed a 55% homology, higher than the percentage of any other member of the family. IL-17 family members were located on different chromosomes except IL-17A and IL-17F, which were located on chromosome 1 in mouse and 6 in human. IL-17A and IL-17F were highly expressed by activated effector memory T cells. Recent observations, however, revealed that cells from innate compartment can also produce IL-17. Recent identification showed that IL-17A and IL-17F can form heterodimers and are produced in a coordinated fashion by T h 17 cells. IL-17A and FRs are expressed on all tissue cells. Furthermore, activation via the IL-17R induces pro-inflammatory cytokines such as IL-1, IL-6 and TNF-a chemokines like C-X-C motif chemokine (CXCL) 8/murine IL-8 homolog and matrix metalloproteinases (28) .
Interplay between induced T reg and T h 17 cells
Since IL-23 could expand IL-17 cells from an activated T cell population, it was suggested that IL-23 is the differentiation factor for T h 17 cells. It was difficult, however, to understand how IL-23 could induce T h 17 differentiation from naive CD4 + T cells since IL-23R expression was found only on activated effector or memory T cell compartment. Naive T cells when activated in the presence of IL-23 could not differentiate into T h 17 cells (29) (Fig. 2) . In 2006, three papers from different laboratories showed that transforming growth factor b (TGF) in combination with IL-6 induced T h 17 differentiation from naive CD4 + T cells (29) (30) (31) (Fig. 2) . Although IL-23 failed to drive the differentiation of naive CD4
+ T cells into T h 17 cells, IL-23 was required for their T h 17 cell expansion/maintenance ( Fig. 3) (30) . The differentiation factors of T h 17 cells suggested that TGF-b, an anti-inflammatory cytokine, works with IL-6, a pro-inflammatory factor, to induce this highly proinflammatory subset of T cells. TGF-b was known as an immunosuppressive cytokine with pleiotropic functions (32) ; because a genetic deficiency of TGF-b induces lymphoproliferation and autoimmunity, it was obvious that TGF-b maintains immune homeostasis and maintains tissue tolerance (33, 34) . The role of TGF-b in regulating the immune response became more clear with the discovery that TGF-b induces forkhead box protein P3 (Foxp3) + T reg cells from naive CD4
+ T cells (35, 36) . Moreover, TGF-b is required for the maintenance and function of natural Foxp3 + T reg (nT reg ) cells (37) . Foxp3 is a transcription factor expressed in nT reg cells and induced by TGF-b in Foxp3
cells] (37) (Fig. 2) . Mutation in the Foxp3 gene in mice or humans induces a devastating autoimmune disease, resulting in the multi-organ inflammatory disease known as scurfy in mice and immunodysregulation, polyendocrinopathy, enteropathy, X-linked in humans (38) . It was surprising and interesting that the presence of pro-inflammatory cytokines such as IL-6 could make effector T cells refractory to T reg cell-mediated suppression (39) . Our group further demonstrated that during EAE, T reg cells in the central nervous system (CNS) lose their ability to suppress an immune response due to the presence of the pro-inflammatory environment (40) . Strikingly, Veldhoen et al. (30) suggested that CD4 + T cell activation in the presence of nT regs and LPS-activated + T reg cells and the presence of IL-6 inhibits TGF-b-mediated Foxp3 induction while inducing T h 17 cells, we proposed that there is a reciprocal relationship between T reg and T h 17 cells. This reciprocal relationship has now been confirmed in many other experimental conditions (48) . Our group further demonstrated that retinoic acid increases the expression and phosphorylation of SMAD family member 3, which enhances Foxp3 expression. Retinoic acid also inhibits the expression of IL-6Ra, IL-23R and IFN regulatory factor 4 (IRF-4), which further inhibits T h 17 generation (49). IRF-4-deficient mice did not develop EAE and IRF-4-deficient T cells were failed to differentiate into T h 17 cells with less expression of T h 17 transcription factor (discussed in T h 17-specific transcription factor) (50, 51) . Recent report further demonstrated that retinoic acid negatively regulates CD4 + CD44 hi memory phenotypes. These memory cells actively inhibit the TGF-binduced Foxp3
+ T reg cells via synthesis of IL-4, IL-21 and IFN-c; expression of these cytokines was coordinately curtailed by retinoic acid (52) . The reciprocal relationship between T h 17 and T reg cells was further exemplified in IL-2-deficient mice (53) . Since IL-2 helps in T cell proliferation and serves as a growth factor for both T h 1 and T h 2, it was predicted that IL-2 would also help T h 17 generation and expansion. IL-2-deficient mice, however, suffer from spontaneous colitis and inflammation (54) . Distinct expression of IL-2Ra on T reg cells suggested the requirement of IL-2 for Foxp3 + T reg cell functions (55), partly explaining the autoimmune phenotype of IL-2-deficient mice. Since T h 17 and T reg cells showed the dichotomous relationship, it might be possible that IL-2-deficient mice compensated for a less number of T reg cells with a higher T h 17 frequency. Laurence et al. 
Self-amplification of T h 17 response
One of the features of T h differentiation is 'self-amplification'. IFN-c, through STAT-1, induces T-bet, which further induces IFN-c and further amplifies IFN-c and T h 1 differentiation (58) . Similarly, IL-4 produced by T h 2 subsets amplifies T h 2 differentiation by inducing IL-4 via STAT-6 activation (6). IL-17 produced by T h 17 cells does not amplify T h 17 cells since IL-17 is neither a growth nor a differentiation factor and its receptor is not expressed on T cells (28) . T h 17, however, cells produce enormous amounts of IL-21, a member of the IL-2 family cytokine, which uses a common c chain receptor. IL-21R is expressed on all T and B cells (40, 59) . IL-21, in combination with TGF-b, induces de novo T h 17 differentiation. Cells such as NKT and NK cells that produce IL-21 can support T h 17 differentiation in certain conditions in the absence of IL-6 (40, 59) . Both IL-6 and IL-21 induce the expression of IL-23R on T h 17 cells (60) . Similarly, IL-23 has also shown to induce its own receptor on both mouse and human T h 17 cells (23, 61) . IL-6 also triggers IL-21 production, which synergizes with TGF-b to initiate and further amplify the T h 17 response while IL-23 produced by activated DCs sustains and stabilizes the differentiation of T h 17 cells (40, 60) (Fig. 3) . IL-21 and IL-21R deficiency showed diminished expression of IL-23R, resulting in the blunt T h 17 generation (60) . Since exposure to IL-23 is the key feature that determines the pathogenicity of T h 17 cells, IL-21 initiates the IL-23R expression on T h 17 cells; therefore, IL-21 not only amplifies T h 17 differentiation but also helps T h 17 attain mature phenotypes by inducing the expression of IL-23R (Fig.  3) . IL-21R-or IL-21-deficient mice develop EAE at a similar frequency to the wild-type control mice (62) , raising the issue of whether IL-21 is important in vivo for the generation of T h 17 cells. It should be noted that the induction of EAE by strong stimuli such as CFA might override the effect of IL-21 by producing enormous amounts of IL-6 in vivo and might thus compensate for IL-21 deficiency in vivo. Recent data, however, show that IL-21-deficient non-obese diabetic mice are highly resistant to type 1 diabetes (63), an autoimmune disease that arises spontaneously. Whether this is due to the loss of IL-17 in these IL-21RÀ/À mice has not, however, been analyzed.
Negative regulation of T h 17 cells
Although T h 17 cells play a protective role against certain extracellular pathogens, a dysregulated T h 17 response can induce severe tissue inflammation and autoimmunity and can be dangerous for the host. T h subsets cross-regulate each other's functions by virtue of the cytokines that they produce, allowing the amplification of the same subset and inhibition function of the other. Thus, T h 1 and T h 2 subsets limit one another's response by the cytokines they produce. Here we have described the cytokines and other factors that negatively regulate this newly described T h lineage.
IL-27, a member of IL-12 cytokine family, has originally been described as a potent inducer of the IFN-c response from T cells (64) . Since IL-27R shares the gp130 subunit of the IL-6R with a unique chain called IL-27Ra, it was difficult to predict whether IL-27 could promote or inhibit T h 17 response. Initial work suggested that IL-27 induces T-bet and IFN-c and, thus, induces T h 1 effector cells (65) . Emerging data on IL-27 associated with different T h 1 and T h 2 pathogens, however, showed that IL-27 is a negative regulator of both the T h 1 and T h 2 response. Toxoplasmosis is a parasitic infection that requires a T h 1 response for its clearance from the host. Mice deficient in either IL-12 or IFN-c die because of high parasite burden. While IL-27R-deficient mice show the normal T h 1 response and clearance of parasite, they die of fatal and severe immunopathology (66) . Similar results were obtained from using different pathogens such as Leishmania and Mycobacteria (67, 68). The immunopathology in the IL-27R-deficient mice was associated with an exaggerated T h 17 response, suggesting that IL-27 may negatively regulate T h 17 cells. Direct evidence came in 2006 showing that IL-27 negatively regulates the T h 17 response both in Toxoplasma gondii infection as well as in MOG peptide-induced EAE. An increased number of T h 17 cells were detected in the CNS in both models of the IL-27R-deficient mice (69, 70) , an observation that agreed the IL-27 inhibition of T h 17 differentiation in vitro. Moreover, IL-27 inhibits T h 17 differentiation at the transcriptional level as it inhibited the expression of retinoid-related orphan receptor (ROR) ct. Unlike IL-6, which inhibited the induction of iT reg generation with a concomitant increases of the T h 17 response, IL-27 inhibited both T h 17 and iT reg induction (71) . The establishment of IL-27 as an inhibitory cytokine for the T h 1, T h 2 and T h 17 response suggested a possibility that it might induce other factors or induce T cell differentiation that inhibits T h 1 and T h 17 responses. A series of papers recently showed that IL-27 induces IL-10-producing T cells (71) (72) (73) , raising the possibility that IL-27 might inhibit T h 17 generation and other effector T cells via IL-10. More importantly, IL-27 inhibits the T h 17 response independent of IL-10 as well. Nevertheless, IL-10 provides an additional mechanism of regulation that may not be required directly to regulate T h 17 generation but rather through the inhibition of antigenpresenting functions. Another study demonstrated that IFNRa-mediated signaling inhibits a translational isoform of osteopontin (OPN), resulting in the inhibition of the T h 17 response. The IFNRa-mediated inhibition of OPN further increases IL-27 expression. Similarly, OPN-deficient DCs produce higher levels of IL-27, which inhibits T h 17 response (74, 75) .
T h 17-specific transcription factors
T h subsets and specific cytokine patterns in T h cells are defined by lineage-specific transcription factors. Antigenspecific activation of the TCR in the presence of cytokine signals helps T cells to differentiate into a specific T h subset. T h 1 differentiation requires STAT-4 and STAT-1 activation by IL-12 and IFN-c, respectively. These cascades of cell signaling activate a lineage-specific transcription factor, T-bet, for a mature T h 1 response. Similarly, STAT-6 and GATA-3 are important for T h 2 differentiation. T h 17 cells were identified as an independent lineage since neither T h 1 transcription factors, such as STAT-1, STAT-4 and T-bet, nor T h 2, such as STAT-6 and GATA-3, was found to be expressed by T h 17 cells. In fact TGF-b, which constitutes a major factor in T h 17 differentiation, inhibits both T h 1 and T h 2 differentiation by inhibiting T-bet and GATA-3, respectively (76, 77) . IL-6, IL-21 and IL-23 are the key factors of T h 17 differentiation. All these factors induce phospho-STAT-3, an observation supported by the fact that the conditional deletion of STAT-3 in T cells reduced the frequency of T h 17 cells, leading to EAEresistant mice (78, 79) . Moreover, the deletion of suppressor of cytokine signaling 3 (SOCS3), which is a negative regulator of STAT-3 signaling, increased the number of T h 17 cells (80) . The over-expression of the hyperactive form of STAT-3 potentiated T h 17 generation. STAT-3 regulates IL-23R and IL-21 expression, both of which are required for amplifying T h 17 generation (Fig. 3) . Initial studies showed that ROR-ct, a member of the retinoic acid receptor-related orphan nuclear hormone receptor family, encoded by the RAR-related orphan receptor C gene is expressed specifically in T h 17 differentiation conditions (TGF-b + IL-6 or IL-21) (81) (Fig. 3) . Retroviral induction of ROR-ct into naive CD4 + T cells induces IL-17A and IL-17F production (81). Analysis of mice in which ROR-ct is expressed with a green fluorescent protein (GFP) label revealed that all the GFP + CD4 + T cells produce IL-17 in the lamina propria. Furthermore, ROR-ct deficiency attenuates the induction of EAE (81) . Recent data showed that TGF-b alone is sufficient to induce both ROR-ct and Foxp3, the transcription factors required for T h 17 and T reg cell induction, respectively (56) . Presence of IL-6 or IL-21 inhibits Foxp3 induction or relieves the suppression that further potentiates T h 17 generation. A low dose of TGF-b synergizes with IL-6 and IL-21 to induce T h 17 generation. A higher dose of TGFb, however, inhibits IL-23R expression with a concomitant increase of Foxp3 expression, favoring the generation of T reg cells (56) . Recent data suggest that Runt-related transcription factor 1 (Runx1) also influences T h 17 generation by inducing ROR-ct expression. Runx1 induces ROR-ct expression by binding to ROR-ct and acting together with ROR-ct to induce IL-17 transcription. Runx1 also interacts physically with Foxp3 to negatively regulate T h 17 differentiation (82) . Altogether, these observations suggest that ROR-ct is essential for the generation of the T h 17 cell. It has not been addressed so far, however, whether ROR-ct directly transactivates the expressions of IL-17A, IL-17F, IL-22 and IL-21. ROR-ct-deficient mice develop EAE but at lesser extent with the residual T h 17 cells, suggesting a possibility of another transcription factor for T h 17 development. ROR-a, another member of the retinoic acid receptor-related orphan nuclear hormone receptor family, is highly expressed in T h 17 cells in a STAT-3-dependent manner by the combination of TGF-b and IL-6 (Fig. 3) ; therefore, ROR-ct and ROR-a may act synergistically to induce T h 17 cells (83) . Recent observations demonstrated that the inducible co-stimulatory molecule (ICOS) is required for the generation of T h 17 cells and follicular helper (T FH ) cells (84, 85) . The generation of T FH cells with the distinct surface phenotype (CD4 + CCR5 + ICOS high ) are dependent on IL-21, IL-6 and STAT-3 (84). T FH showed highly specialized functions in the generation of germinal centers and helped in somatic hypermutation, class switching and the selection of high-affinity B cells. Both T h 17 and T FH cells showed a higher expression of proto-oncogene c-maf (c-maf), which was thought to be a T h 2-specific transcription factor. C-maf deficiency, in turn, resulted in defective IL-21-mediated IL-23R expressions. Our group showed that ICOS-induced c-maf, in fact, helps in the generation of T FH and T h 17 cells. Although the requirement of c-maf is essential for the expansion of T FH cells, unlike T h 17 cells (85), the differentiation of T FH cells did not require T h 17-specific transcription factors, ROR-ct and ROR-a (84).
Human T h 17 cells
The identification of differentiation factors in the murine model led us and others to determine the similarities in T h 17 differentiation between human and murine T cells, which would provide therapeutic targets of T h 17-mediated inflammation. T h 17 cells and their products are associated with the pathology of many inflammatory and autoimmune diseases. IL-17 has not only been detected in the lesions of multiple sclerosis but also been believed to compromise the blood brain barrier (86, 87) . Similarly, higher amounts of IL-17 and T h 17 cells were found the synovium of rheumatoid arthritis patients than in healthy patients (20) . High levels of both IL-17 and IL-23 were detected in patients of Crohn's disease and ulcerative colitis (88, 89) . These observations agree with the mouse model data of these autoimmune diseases. Initial data on identifying factors for human T h 17 cell differentiation, however, suggested that TGF-b is not required for the differentiation of T h 17 cells. Instead, IL-1b and IL-6 or IL-1b in combination with IL-23 induces T h 17 differentiation (90, 91) . Another report suggests that IL-23 alone is sufficient to drive human T h 17 differentiation (61) . Instead of positively effecting T h 17 differentiation, TGF-b inhibited human T h 17 generation (90) . This inhibition was in striking contrast with the murine system where TGF-b is absolutely required for T h 17 differentiation (29) . The description of IL-21 as growth factor for T h 17 development in the mouse model raised the possibilities that IL-21 is the differentiating cytokine for human T h 17 differentiation. Subsequent work on human T h 17 cell differentiation revealed that the presence of endogenous TGF-b in the serum containing media is sufficient to induce human T h 17 differentiation in the absence of exogenous TGF-b (92) . Moreover, addition of TGF-b in the serumfree media with IL-1b and IL-6, IL-21 or IL-23 is sufficient to induce human T h 17 differentiation from naive human CD4 + T cells (92) . We made similar observations that while IL-6 and IL-1b induce IL-17 production from human central memory cells, a combination of TGF-b and IL-21 induces human T h 17 differentiation from naive T cells (93) . Besides the differentiating factors, human and mouse T h 17 cells express similar cytokines, such as IL-17A, IL-17F, IL-22 and IL-21, and cell surface receptors, such as IL-23R and C-C chemokine receptor type 6 (94, 95) .
T h 17 cells in autoimmunity
T h 1 cells could not explain their crucial role in the induction of autoimmune inflammation since the depletion of T h 1-specific molecules did not decrease the susceptibility of autoimmune inflammation such as EAE. In fact, mice showed enhanced disease. Discovery of the IL-23 and T h 17 axis has defined T h 17 cells as the dominant effector T cell for inducing autoimmune tissue inflammation (14) . Association of IL-17 with human autoimmune disease was first demonstrated in patients of rheumatoid arthritis. In these patients, a higher frequency of T h 17 cells had been detected in the arthritic synovium. Furthermore, IL-17 had been shown to induce the production of IL-6, IL-8 and TNF-a from the human synovial cells that induce tissue inflammation. Similarly, T cellmediated production of IL-17 had been detected in the active lesions in the brain of multiple sclerosis patients (86) . Increased frequencies of T h 17 cells and IL-17 have also been shown in the patients of inflammatory bowel disease and psoriasis (89, 96) . Altogether, these observations imply that T h 17 cells are required for the induction of tissue inflammation and pathology during autoimmune diseases. Both IL-17A and F activated tissue cells to promote inflammation by producing pro-inflammatory cytokines (IL-6, TNF-a and IL-1b) and chemokines (CXCL1, granulocyte chemotactic protein 2, CXCL8, cytokine-induced neutrophil chemoattractant and monocyte chemoattractant protein 1) helped neutrophil infiltration at the site of the target organ. IL-17 further potentiates tissue pathology by inducing the production of nitric oxide and matrix metalloproteinases. IL-17 has also showed its destructive effects on bone and cartilage by activating osteoclasts and is, therefore, called the osteoclastogenic T h cell subset that links T cell activation and bone resorption (97) . The effects of IL-17 have also been demonstrated in different mouse models of autoimmune disease, such as EAE and collagen-induced arthritis (CIA). IL-17-deficient mice exhibited a delayed onset and reduced disease severity, followed by early recovery in EAE (98) . Similarly, IL-17-deficient mice develop attenuated CIA (99) . These data were corroborated with a higher level of IL-17 expression in the target tissues in the animal models of EAE and CIA. Furthermore, CD4
+ T cells from IL-17-deficient mice failed to transfer EAE to the recipient mice, suggesting the dominant function of CD4 + -mediated IL-17 production in the induction of EAE. Consistently, therapeutic neutralization of IL-17 with IL-17R-Fc protein in acute EAE ameliorated clinical symptoms of EAE, further confirming the fact that IL-17 instead of IFN-c is the dominant cytokine for the pathogenesis of EAE (100). A recent study described that IL-17A triggered positive feedback loop of IL-6 signaling, which involved the activation of the transcription factors NFjB and STAT-3 in fibroblasts and contributed to the development of arthritis and EAE (101) . SOCS3 negatively regulated this positive feedback and inhibited an IL-17-mediated exacerbation of disease. IL-6 is an important factor for the generation of T h 17 cells. Increased levels of IL-6 have been shown in autoimmune diseases such as multiple sclerosis and arthritis. The blockade of IL-6 by humanized IL-6R antibody showed the exciting clinical results in a phase II clinical trial in rheumatoid arthritis and systemic onset juvenile idiopathic arthritis patients (102) . Blocking of IL-6 might decrease the frequency of T h 17 in these patients and might increase T reg -associated functions.
Taken together, these data suggest that T h 17 cells are the major contributor of autoimmune inflammation in various autoimmune diseases and may be good therapeutic target for inflammation.
T h 17 cells in infection
Although the discovery and description of T h 17 cells are mainly associated with autoimmune diseases, emerging data suggest the role of these newly described subsets in infection and host defense. The T h 1 subset has been described as effector subset of T cells that activates macrophages and help in clearing the intracellular pathogens. Similarly, T h 2 cells are crucial for clearing the extracellular pathogens. Interestingly, the effector functions of T h 17 cells have been described in the context of autoimmunity. Emerging data, however, suggest the crucial role of T h 17 cells in mounting the immunity for both intracellular and extracellular pathogens. Both IL-17A and IL-17F are induced in several models of infections, suggesting the involvement of this newly described helper subset (103) . IL-17 up-regulates specific chemokines, pro-inflammatory cytokines and colonystimulating factors (CSFs), thereby helping to induce neutrophils and other myeloid cells recruitment at the site of infection. The cellular recruitment at the site of infection is the crucial process in many infections. Many pathogens including Mycobacteria and Pneumocystis carinii induce IL-23 secretion from infected macrophages and DCs that helps in the generation of T h 17 cells. IL-23p19-deficient mice were unable to clear the P. carinii infection (104) . Similar results have been observed with IL-17 neutralization in this infection, suggesting that the IL-23-IL-17 axis is required for the anti-fungal immune response (104) . In addition to fungal pathogens, IL-17 is also essential for the protection against gram-negative bacteria, including Klebsiella pneumoniae. IL-17R-, IL-23p19-and IL-12p40-deficient mice were susceptible to the K. pneumoniae infection associated with a reduced expression of CSFs and neutrophil recruitment. In addition to IL-17, IL-22 increased lung epithelial cell proliferation and increased transepithelial resistance to injury in K. pneumoniae infection (105) . IL-17 also appears to play an important role in the Mycobacteria infection. The cellular source of IL-17 plays an important role in anti-mycobacterial functions (106) . It has been demonstrated that gamma delta T cells quickly and rapidly produce IL-17 during mycobacterium infection (107) . IL-17 derived from CD4 + T cells, however, is also required not only for the clearing of the primary infection but also to establish effective memory responses (108) . A role for IL-17 in Lyme disease has also been reported. Both human and mouse T cells produced enhanced amount of IL-17 in response to the Borrellia burgdorferi infection (109) . T h 17 cells could bridge the gap between innate and adaptive immunity and could attract other subsets of T h cells and cells of innate compartment including neutrophils and macrophages to sites of infection for efficient clearing of the pathogens. This has most convincingly been shown in the Mycobacterium tuberculosis infection, for which an early T h 17 response is required to bring T h 1 cells into the infected lung tissue to control the infection. Genetic deficiency in mounting an effective IL-17/ T h 17 response in humans results in unrelenting mucocutaneous infections and staphylococcal lung infections as seen in Job's syndrome (110) .
Concluding remarks
T h 17, a third subset of T h effector cells, has been identified as critical for many T cell responses and is required for autoimmunity and tissue inflammation. Substantial progress has been made to understand the biology of T h 17 cells in various autoimmune and infection models. We and others have shown the reciprocal generation of 
